We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
-15.27%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$4.8B
AUM Growth
-$1.19B
Cap. Flow
-$217M
Cap. Flow %
-4.53%
Top 10 Hldgs %
27.77%
Holding
137
New
6
Increased
15
Reduced
102
Closed
6

Top Buys

Rank Stock Value
1
TWOU
2U Inc
TWOU
+$53.3M
2
GWRE icon
Guidewire Software
GWRE
+$40.8M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$34.4M
4
BL icon
BlackLine
BL
+$33.4M
5
LIN icon
Linde
LIN
+$24.2M

Top Sells

Rank Stock Value
1
ATHN
Athenahealth, Inc.
ATHN
+$112M
2
MD icon
Pediatrix Medical
MD
+$31.2M
3
PRAA icon
PRA Group
PRAA
+$28.7M
4
PX
Praxair Inc
PX
+$25.6M
5
MMS icon
Maximus
MMS
+$23.2M

Sector Composition

Rank Sector Weight
1 Technology 31.45%
2 Industrials 21.15%
3 Healthcare 19.96%
4 Consumer Discretionary 10.56%
5 Consumer Staples 4.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IUSG icon
101
iShares Core S&P US Growth ETF
IUSG
$30.7B
$2.16M 0.05%
+41,044
New +$2.33M
PAYX icon
102
Paychex
PAYX
$44B
$2.08M 0.04%
31,926
-2,181
-6% -$148K
PG icon
103
Procter & Gamble
PG
$339B
$2.02M 0.04%
21,984
-1,253
-5% -$112K
CL icon
104
Colgate-Palmolive
CL
$74.2B
$1.56M 0.03%
26,147
-6,353
-20% -$397K
ATHN
105
DELISTED
Athenahealth, Inc.
ATHN
$1.36M 0.03%
10,321
-874,934
-99% -$112M
CAH icon
106
Cardinal Health
CAH
$54.3B
$740K 0.02%
16,581
-10,359
-38% -$540K
JPM icon
107
JPMorgan Chase
JPM
$929B
$727K 0.02%
7,445
-3,130
-30% -$333K
EFX icon
108
Equifax
EFX
$22.1B
$723K 0.02%
7,764
-6,689
-46% -$712K
SLB icon
109
SLB Ltd
SLB
$73.2B
$621K 0.01%
17,211
-16,566
-49% -$817K
IWB icon
110
iShares Russell 1000 ETF
IWB
$47.5B
$508K 0.01%
3,662
-166
-4% -$24.8K
SUSA icon
111
iShares ESG Optimized MSCI USA ETF
SUSA
$3.96B
$410K 0.01%
+7,952
New +$441K
USB icon
112
US Bancorp
USB
$99B
$395K 0.01%
8,637
-1,194
-12% -$61.5K
BRK.B icon
113
Berkshire Hathaway Class B
BRK.B
$1.1T
$336K 0.01%
1,645
– –
MD icon
114
Pediatrix Medical
MD
$2.18B
$332K 0.01%
10,067
-776,629
-99% -$31.2M
BMY icon
115
Bristol-Myers Squibb
BMY
$130B
$303K 0.01%
5,825
– –
SYK icon
116
Stryker
SYK
$134B
$298K 0.01%
1,900
– –
ILMN icon
117
Illumina
ILMN
$29.1B
$277K 0.01%
951
– –
KO icon
118
Coca-Cola
KO
$386B
$270K 0.01%
5,704
– –
WFC icon
119
Wells Fargo
WFC
$258B
$261K 0.01%
5,671
-1,060
-16% -$54.3K
ORCL icon
120
Oracle
ORCL
$342B
$226K ﹤0.01%
5,000
– –
AGCO icon
121
AGCO
AGCO
$8.41B
– –
-3,457
Closed -$210K
TGT icon
122
Target
TGT
$66.6B
– –
-2,586
Closed -$228K
CERN
123
DELISTED
Cerner Corp
CERN
– –
-14,116
Closed -$909K
PX
124
DELISTED
Praxair Inc
PX
– –
-159,585
Closed -$25.6M
1 2 3 4
5

Similar funds

BPS
BNDES Participacoes SA Rio De Janeiro, Brazil $3.58B AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
WWA
WCG Wealth Advisors Las Vegas, Nevada $3.57B AUM 18.63% 1-Year Est. Return
SPC
Sigma Planning Corp Ann Arbor, Michigan $3.6B AUM 24.57% 1-Year Est. Return
U
Uber San Francisco, California $3.6B AUM 19.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $3.54B AUM 19.14% 1-Year Est. Return

Riverbridge Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Riverbridge Partners held 137 positions worth $4.8B, down 20% from $5.98B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Riverbridge Partners withdrew a net $217M in Q4 2018, closing 6 positions and reducing 102 holdings. Its most notable exit was Praxair Inc, an estimated $25.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Riverbridge Partners opened a new position in Guidewire Software worth $37.5M.

  • Riverbridge Partners's largest Q4 2018 buy was Guidewire Software: 467,694 shares worth $37.5M.
  • Riverbridge Partners added most to 2U Inc in Q4 2018, an estimated $53.3M increase.
  • Riverbridge Partners's biggest Q4 2018 reduction was Athenahealth, Inc., cutting an estimated $112M.
  • Riverbridge Partners fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Riverbridge Partners's ten largest holdings make up 28% of its $4.8B portfolio in Q4 2018.
  • Riverbridge Partners opened 6 new positions and closed 6 in Q4 2018.
  • Riverbridge Partners's portfolio value fell 20% quarter-over-quarter to $4.8B.

Based on Riverbridge Partners's 13F filing for Q4 2018, filed 14 Jan 2019.